CYBIN INC.
corporate_fare Company Profile
CYBIN INC. (NASDAQ:HELP) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 26 items for HELP at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-11, rated 9/10. Across its 20 most recent items scored 7 or higher, the top rating is 10/10, with 15 rated 8 or above. Recent SEC coverage for HELP spans 4, SCHEDULE 13D, 6-K, 40-F.
Recent high-impact activity:
- Chief Growth Officer Adds $1.25M More — Third Purchase in Three Days
- Executive Chair Eric So Buys $1.21M of Cybin Stock at $12.09
- Chief Growth Officer Adds $1.18M More — Now Holds 4.17M Shares
- Executive Chair Eric So Discloses 5.8% Stake After $1.12M Open-Market Buy
- Chief Growth Officer Discloses 5.8% Stake, Including $1.04M Open Market Purchase
Financial Snapshot
Dilution Risk
Low riskFiling-implied dilution signals for HELP, detected from its recent SEC filings · based on capital-structure filings through 2026-06-25.
Underwritten Offering Priced · Substantial Share Dilution
⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →
Insider Transactions
HELP files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.